Fengsheng Chen

机构：TCM-Intigrated Cancer Center of Southern Medical University, Jiangxi University of Science and Technology, Southern Medical University · ORCID：0000-0001-5806-4638

发表论文 71 篇 · 总被引 684 次 · h-index 15

代表论文

• Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction (2024 · Journal of Advanced Research · 被引 16)
• THSWD upregulates the LTF/AMPK/mTOR/Becn1 axis and promotes lysosomal autophagy in hepatocellular carcinoma cells by regulating gut flora and metabolic reprogramming (2025 · International Immunopharmacology · 被引 14)
• Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor (2024 · Phytomedicine · 被引 14)
• Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling (2023 · International Immunopharmacology · 被引 14)
• Kaempferol Remodels Liver Monocyte Populations and Treats Hepatic Fibrosis in Mice by Modulating Intestinal Flora and Metabolic Reprogramming (2024 · Inflammation · 被引 10)
• Ammonium tetrathiomolybdate attenuates acetaminophen-induced acute liver failure by inhibiting the TRPV4/Calcium/NF-κB signaling pathway (2025 · Biochemical Pharmacology · 被引 7)